Suzhou Novoprotein Soars 20% to Intraday High of CNY 80.99

Suzhou Novoprotein Scientific Co., Ltd. has experienced significant activity today, with the stock surging by 20.0% on August 21, 2026. The stock reached an intraday high of CNY 80.99, marking a notable performance compared to the China Shanghai Composite, which saw a modest increase of 0.04% on the same day. Over the past week, Suzhou Novoprotein has shown a robust performance, climbing 16.4%, while its one-month performance stands at an impressive 126.86%. Year-to-date, the stock has gained 102.22%, significantly outperforming the broader market, which has declined by 1.6%. Despite these short-term gains, the company faces challenges, including a low Return on Capital Employed (ROCE) of 3.40% and a concerning Debt to Equity ratio. Additionally, the company has reported negative results for the last ten consecutive quarters, with a net profit of CNY -28.86 million. As a small-cap player in the miscellaneous industry, Suzhou Novoprotein's recent stock performance highlights a complex financial landscape, characterized by both notable gains and underlying financial difficulties.